Fig. 1 · Structure
Documents & Downloads
HYNIC-PSMA
Tumor Molecular Ligand
HYNIC-PSMA is a molecular imaging ligand targeting the Prostate-Specific Membrane Antigen (PSMA), which is predominantly expressed on prostate cancer cells. The compound combines 6-hydrazinonicotinamide (HYNIC) for the attachment of radioactive isotopes, facilitating the development of radiolabeled agents like 188Re-HYNIC-PSMA. HYNIC-PSMA is essential for prostate cancer research and supports the synthesis of Radionuclide-Drug Conjugates (RDCs), enhancing imaging and therapeutic applications in oncology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Ligand / Binder |
| CAS Number | 2213408-17-2 |
| Applications | Tumor Molecular Ligand |
| Formula | C24H37N7O9 |
| Molecular Weight | 567.59 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.